Insmed Announces Proposed $500 Million Public Offering of Common Stock

BRIDGEWATER, N.J., May 28, 2024 /PRNewswire/ -- Insmed Incorporated , a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today...

Related Keywords

United States ,New Jersey ,Boston ,Massachusetts ,Japan ,Bridgewater ,New York ,Japanese ,Mandy Fahey ,Pharma Gmb ,Eleanor Barisser ,Esteve Pharmaceuticals ,Syndicate Department ,Thermo Fisher Scientific Inc ,Prospectus Department ,Drug Administration ,Leerink Partners ,Prnewswire Insmed Incorporated Nasdaq ,Insmed Incorporated ,Goldman Sachs Co ,Exchange Commission ,Company Annual Report On Form ,Corporate Communications ,Goldman Sachs ,Private Securities Litigation Reform Act ,Nebuliser Dispersion ,Nebulizer System ,Pharmakon Advisors ,Orbimed Royalty ,Thermo Fisher Scientific ,Annual Report ,